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Human milk provides the optimal balanced nutrition for the growing infant in the ﬁrst months after
birth. The human mammary gland has evolved with unusual pathways, resulting in a speciﬁc
positioning of fatty acids at the outer sn-1 and sn-3, and center sn-2 of the triacylglyceride, which is
different from the triglycerides in other human tissues and plasma. The development of structured
triglycerides enables mimicking the composition as well as structure of human milk fat in infant
formulas. Studies conducted two decades ago, together with very recent studies, have provided
increasing evidence that this unusual positioning of 16:0 in human milk triglycerides has a signiﬁcant
role for infant health in different directions, such as fat and calcium absorption, bone health, intestinal
ﬂora and infant comfort. This review aims to unravel the relevance of human milk triglyceride sn-2 16:0
for intestinal health and inﬂammatory pathways and for other post-absorption effects.
& 2013 Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Human breast milk provides the optimum nutrition for infants,
and is being designed to provide perfectly balanced nutrition to
meet the needs of the growing infant in the ﬁrst months after
birth. About 50% of energy in human milk is provided by fatty
acids in the milk triglycerides, which themselves are molecules
comprised of mixtures of three fatty acids esteriﬁed to a glycerol
backbone [1]. Triglyceride synthesis, rather than involving ran-
dom esteriﬁcation of three fatty acids to glycerol, involves speciﬁc
positioning of fatty acids at the outer sn-1 and sn-3, and center sn-
2 positions of the triacylglyceride. The human mammary gland
has evolved with unusual pathways for acylation of fatty acids
into triglycerides for secretion in milk, with these pathways
resulting in a different triglyceride structure (triglyceride fatty
acid arrangement) from the triglycerides in other human tissues
and plasma [2], or common dietary fats and oils. This stereo-
speciﬁc positioning of fatty acids in human milk triglycerides
involves preferential positioning of the saturated fatty acid
palmitic acid (16:0) at the sn-2 position, rather than at the sn-
1,3 positions, as is typical of human tissue and plasma lipids, and
vegetable oils common in human diets, and in the fat blends used
in the manufacture of infant formula [3]. Studies over the last two
to three decades have provided increasing evidence that this
usual positioning of 16:0 in human milk triglycerides promotes
the absorption of both 16:0 and calcium in term and preterm
infants [4–8]. However, the importance of the sn-2 positioning ofr-Yoseph).
C-ND license. 16:0 in human milk triglycerides is expected to extend beyond
saturated fatty acids and calcium absorption, since it also impacts
the composition of unesteriﬁed fatty acids in the intestinal lumen,
and the composition of unesteriﬁed fatty acids and sn-2 mono-
glycerides that enter the intestinal enterocyte. Recently, there has
been a growing understanding that dietary fatty acids may
inﬂuence the intestinal microbiome and contribute in complex
ways to neurological and immune system development through
roles in cell signaling and regulation of gene expression. This
paper provides a review of new studies with triglycerides synthe-
sized to contain 16:0 on the sn-2 (also termed b-16:0) and 18:1n-
9 on the sn-1, 3 position to resemble the major 16:0 containing
triglyceride species in human milk. Our purpose is to begin to
unravel the relevance of human milk triglyceride sn-2 16:0 for
intestinal health and inﬂammatory pathways and for other post-
absorption effects.2. Structured triglycerides
Palmitic acid (C16:0) is the major saturated fatty acid in
human milk, accounting for 17–25% of the total fatty acids [2].
Equally important, over 70% of 16:0 is esteriﬁed at the milk
triglyceride sn-2 position [2,9]. The major unsaturated fatty acid
in human milk is oleic acid (18:1n-9) and this is mostly esteriﬁed
at the triglyceride sn-1,3 (outer) positions, with the result that
triglycerides with the structure 18:1n-9—16:0—18:1n-9 are a
major triglyceride species in human milk and represent an
estimated 11.8% of the total triglyceride species [2]. Early studies
addressing the importance of the human milk triglyceride struc-
ture compared fat absorption in infants fed human milk with
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which 16:0 is also high and esteriﬁed in the triglyceride sn-2
position), and infants fed lard that had been randomized to
redistribute 16:0 equally across all three carbons on the triacyl-
glyceride [10]. The latter studies showed that redistributing 16:0
from the sn-2 position of the formula triglyceride led to decreased
fat absorption. Although two or more vegetable oils can be
blended to give the same average amounts of 16:0, 18:1n-9 and
18:2n-6 in an infant formula as in human milk, the stereo-speciﬁc
arrangement of vegetables oil triglycerides means that the 16:0
will be present almost entirely on the triglyceride sn-1,3 posi-
tions [3]. The development of structured triglycerides enables
mimicking both the composition as well as the structure of
human milk fat for infant formulas. Structured TG are achieved
through an enzymatic process by which the 16:0—18:1n-9—16:0
is transformed to 18:1n-9—16:0—18:1n-9. The resulting product
contains 17–25% palmitic acid with above 40% located at the
center sn-2 position.32003. Importance of dietary 16:0 positioning in triglycerides
for fatty acid and calcium absorption.
Studies done several decades ago have demonstrated the
greater efﬁciency of fat absorption and softer stools in breast-
fed infants compared to that of infants fed with formulas contain-
ing 16:0 from saturated vegetables; effect that was linked to the
large amounts of 16:0 in human milk at the sn-2 position of the
milk triglycerides [4–8]. Triglyceride digestion by endogenous
lipases leads to hydrolysis of fatty acids from the triacylglyceride
sn-1,3 linkages, to release two unesteriﬁed fatty acids and one sn-
2 monoglyceride from each triglyceride into the intestinal lumen
[11]. A role for the milk bile salt-stimulated lipase in completing
hydrolysis of sn-2 monoglycerides with 16:0 released during
triglyceride digestion is unlikely, since unesteriﬁed 16:0 is poorly
absorbed [3]. Structuring 16:0 on the triglyceride sn-2 position of
milk or formula fats improves 16:0 absorption [12,13], and
plasma chylomicron triglycerides of breast fed infants are high
in sn-2 16:0 [14,15]. In addition to low intraluminal solubility,
unesteriﬁed 16:0 has an increased tendency to combine with
divalent cations, such as calcium, to form insoluble soaps, which-2
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Fig. 1. Modiﬁed Cohen’s effect size of the effect of the 16:0 position in formula
triglycerides on the absorption of 16:0 and calcium in term and preterm infants.
The percentage of 16:0 in formula triglycerides (x-axis) was plotted against the
mean percentage of 16:0 absorption (open circles or squares) or calcium (solid
circles or squares) reported in clinical studies with preterm (circles) and term
(squares) infants to derive the Cohen effect (f2), as described (Cohen 1988) [17].
The ﬁgure shows that progressive enrichment of 16:0 at the sn-2 rather than
sn-1,3 positions of formula triglycerides leads to a dose response increase in
calcium and 16:0 absorption. The numbers on the data points on the graph refer to
the published studies, as cited in the references.are malabsorbed [16]. Clinical evidence for this has been provided
by studies to show increased fecal excretion of fatty acid soaps of
16:0 and calcium, accompanied by harder stools, in infants fed
formula containing 16:0 from saturated vegetable oils rather than
structured triglycerides containing b-16:0 [4–8]. Fig. 1 shows the
correlation between the level of 16:0 in the milk or formula
triglyceride sn-2 position and infant fatty acid and calcium
absorption calculated as a modiﬁed Cohen’s effect size (f2) [17]
using data from published studies with term [5–7] and preterm
infants [4,8]. Since an effect size of over 0.8 is recognized as a
large effect [17], b-16:0 with over 40% 16:0 at the sn-2 position
would have a large beneﬁcial effect on fatty acid and calcium. The
results show that progressively increasing 16:0 at the sn-2 (and
decreasing 16:0 at the sn-1,3 positions) of the formula triglyceride
leads to a dose-dependent increase in 16:0 and calcium absorp-
tion (r¼0.95 and r¼0.78 for 16:0 and calcium, respectively). The
reduction in fecal calcium and 16:0 as calcium soaps is accom-
panied by a decrease in the incidence of harder stools [6,18,19].4. Bone health
Malabsorption of calcium in fatty acid soaps in infants fed
formulas containing 16:0 rich vegetable oils has led to interest in
the possible effects of milk and formula 16:0 on bone mineraliza-
tion in young infants [6]. Recent advances in methods for
assessment of bone strength parameters with the development
of quantitative measures of bone using supersonic speed of sound
(SOS) have recently been applied to this direction of research.
Ultrasound bone sonometry is a non-invasive technique that
enables quantitative longitudinal assessment of changes in bone
parameters in the tibia or other bones in term and preterm infants
from birth [20–22]. Litmanovitz et al. recently applied the bone
SOS technology in a randomized, controlled, double-blind clinical
study of bone parameters in term infants fed formula containing
triglycerides with sn-2 16:0 from InFats or standard vegetable oil
blends with comparison to a non-randomized group of breast-fed
infants [23]. Tibia bone SOS decreased during the ﬁrst 3 months2600
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Fig. 2. Ultrasound Speed of Sound (SOS) of the tibia of term infants 3 fed with
formula containing 16:0 in structured triglycerides (b-16:0) or unmodiﬁed
vegetable oil, or who were breast-fed. from birth to 12 weeks of age. Data for
each infant within each group is shown by the individual points. The group mean
is indicated by the solid line, with the mean for the group fed b-16:0 (n¼20)
signiﬁcantly higher than for the group fed the standard formula (n¼18) (po0.05),
and not different from the group of the breast-fed infants (n¼22). The formulas
contained about 20% 16:0, with 43% or 14% 16:0 in the sn-2 position of the b-16:0
and standard formulas, respectively.
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using SOS to assess bone in term and preterm infants [24,25].
However, this recent study showed that infants fed 16:0 as b-16:0
had signiﬁcantly higher bone SOS, at about 3 months of age than
in infants fed formula with a standard vegetable oil blend (Fig. 2).
The bone SOS measures for infants fed the b-16:0 formula were
also comparable to those of the group of breast-fed infants [23].
These data conﬁrm and extend studies by Kennedy et al. [6] who
over a decade ago used dual-energy X-ray absorptiometry (DEXA)
to show higher body bone mass in infants after 12 weeks of
feeding with formula containing structured triglycerides enriched
in sn-2 16:0 rather than a conventional formula. In contrast,
Zuccotti et al. [26] recently reported no difference in left tibia
bone SOS between exclusively breast-fed (n¼25) and formula fed
(n¼12) infants at 4 months of age, or when assessed later at 12
months of age; however, the type of formula fed was unspeciﬁed.
Clearly, more studies are needed to assess both the early and
potential longer-term implications of the impact of dietary
triglyceride composition and structure on bone mineralization
and characteristics in infants.5. Intestinal health
Knowledge that triglyceride digestion by endogenous lipases
leads to release of sn-2 monoglycerides and unesteriﬁed fatty
acids [16], and that the triglyceride structure of human milk and
infant formula inﬂuences the composition of fatty acids excreted
in stools raises the question of whether the composition of sn-2
monoglycerides and unesteriﬁed fatty acids in the lumen, or
absorbed into the intestinal enterocytes, also impacts intestinal
development and health. The intraluminal environment is char-
acterized by a complex community of microorganisms, which in
number is far in excess of the eukaryotic cells of the human body
[27]. The intestinal microﬂora is an essential ‘‘organ’’ which
serves numerous important functions, including protection
against pathogens and modulation of inﬂammatory and immune
responses, provision of metabolic intermediates and some vita-
mins, and regulation of intestinal epithelial proliferation and
intestinal maturation [27–29]. Of importance, the fetal intestine
is essentially a sterile environment that becomes colonized at
birth, with the mode of infant delivery, enteral feeding with
human milk or formula, and other environmental factors known
to impact early intestinal colonization [30]. Growing understand-
ing that the composition of intestinal microbiotica is inﬂuenced
by factors in the milk diet of the young infant and that different
types of microbiotica are associated with an increased or
decreased risk of certain diseases, including allergies, late-onset
autism, and inﬂammatory bowel disease [27] has led to recent
interest in the possible role of milk triglyceride structures on the
intestinal microﬂora of young infants. In a recent clinical study,
we found that infants fed formula containing 16:0 as b-16:0 from
InFats had higher numbers of Lactobacilli and Biﬁdobacteria after
6 weeks of feeding than infants fed a control formula with 16:0
from usual vegetable oils [31]. Notably, the beneﬁcial effects of
b-16:0 in increasing Lactobacilli and Biﬁdobacteria were also present
in the subgroup of infants born by Cesarian section, as well as in the
subgroup of infants born vaginally. Lactobacilli and Biﬁdobacteria
have been associated with promotion of gut maturation and
integrity, antagonism against pathogens, and immune modulation
[32,33]. Considerable opportunities exist for further research to
understand the role of the composition of fatty acids in contributing
to the composition of colonizing microﬂora in the young infant’s
intestinal lumen.
In this regard, other recent experimental study has used the
Muc2 deﬁcient mice to address the possible role of milk 16:0content and positioning in triglycerides on intestinal inﬂamma-
tion. Muc2 deﬁcient mice (Muc2/) lack mucin2, which is a
major component of the mucus layer that separates and provides
a physical barrier for the intestinal epithelial cells from the
intraluminal contents [34], protecting the underlying epithelium
against luminal substances and microbes [35–37]. The deﬁciency
of mucins in the Muc2/ mice affects the protective capacities of
the mucus layer [38], and as a consequence, bacteria are in direct
contact with the intestinal epithelial cells [39]. This in turn leads
to the development of spontaneous colitis in Muc2/ mice, a
well-described animal model of enterocolitis [40–42]. In a study
with Muc2/ mice, mice fed 16:0 as InFats demonstrated a
lower extent of intestinal erosions and morphological damage
than mice fed the same amount of 16:0 in an unmodiﬁed
standard vegetable oil blend [43]. Further studies will be needed
to address the mechanisms through which b-16:0 (or unesteriﬁed
16:0) affects this response in Muc2/ mice, as well as the
possible role of effects mediated by changes in the intestinal
microﬂora, or their metabolism.6. Infant behavior
Early infant crying is considered to reﬂect basic, instinctive
responses governed by neurochemical mechanisms similar to
those that control feeding and drinking (i.e., spontaneous beha-
viors) (for a review, see Ref. [44]). Early infant crying follows a
typical pattern over the day, with about 40% of crying episodes
occurring between 16:00 and 22:00 h; it is only after the third
month from birth that crying episodes become more distributed
throughout the day [45,46]. The developmental regulation of
crying coincides with the development of the circadian rhythm
and forms in part the neurobiological/neuroendocrine basis for
the link between crying behavior and the development of circa-
dian rhythms. Crying behavior in young infants is, therefore,
considered as modiﬁable by endogenous/exogenous stimuli that
alter neurochemistry. However, this is complex since early infant
crying includes not only spontaneous endogenous crying but also
crying due to distress, such as separation from an individual to
which the infant has become attached, hunger or other physical
distress. Not unexpectedly, the duration of crying in very young
infants is inversely correlated with the duration of sleep time
[46,47].
In a recent open label study, the percent of daily time spent
sleeping was not signiﬁcantly different between the term gesta-
tion infants fed formula with b-16:0 and breast fed infants at
6 weeks (68.4% and 69.5% respectively) or 12 weeks of age (64.3%
and 67.1% respectively) (unpublished data). Savino et al. (2006)
provided the ﬁrst evidence that triglycerides enriched in b-16:0
might impact infant crying. In this study, term gestation infants
fed a formula containing partially hydrolyzed whey proteins,
prebiotic oligosaccharides, and high 16:0 as b-16:0 (41% of the
formula 16:0 in the triglyceride sn-2 position) showed signiﬁ-
cantly reduced crying compared to infants fed a control formula
without b-16:0 hydrolyzed whey proteins or oligosaccharides
[49]. However, the beneﬁcial effects on crying in this study cannot
be speciﬁcally attributed to the b-16:0. More recently, we found
that among term infants fed formula with b-16:0 for the 12 weeks
after birth there was a decreased percentage of infants that cried,
and lower crying duration during the day and night, and espe-
cially in the evening and night hours, when compared to infants
fed a standard formula with a similar 20% 16:0 but from
unmodiﬁed vegetable oil (Fig. 3). This difference in crying pattern
between infants fed b-16:0 and those fed standard formula
containing 16:0 from unmodiﬁed vegetable oils should probably
be attributed to complex of mechanisms.
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Fig. 3. Total daily crying duration at 12 weeks postnatal. Crying was evaluated by
calculating the mean crying duration per day based on parents’ reports of crying
periods of more than 5 min. At 12 weeks BF infants cried less time during the day
compared to control (17.976.5 vs. 64.0721.8 min. p=0.063). InFat formula fed
infants also tended to cry less compared to control infants (p=0.047).
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triglycerides rich in sn-1,3 18:1n-9 and sn-2 16:0 to altered
spontaneous crying in the ﬁrst few weeks after birth. Structured
triglycerides composed of sn-1,3 18:1n-9 and sn-2 16:0 will lead
to uptake of unesteriﬁed 18:1n-9 and sn-2 16:0 into the intestinal
enterocytes [16]. Several acylated molecules, such as the acyl
ethanolamines and acylglycines, including palmitoyl and oleoyl
ethanolamide are known to be potent signal molecules of the
endocannabinoid system that contribute to regulation of relevant
physiological processes, such as sleep and pain sensitivity [50],
are thought to be involved in the circadian rhythm [51]. Notably,
the endogenous opiatergic system is also known to be involved in
spontaneous crying (for review see [44]). Interestingly, the
developmental regulation of crying coincides with the develop-
ment of the circadian rhythm. This is perhaps a key, whereby
alterations of circadian rhythm development or neuro-endocrine
mechanisms therein may relate dietary variables that perturb
these systems to crying behavior (see for e.g. the work of [52].
Lower crying behavior in the late afternoon among infants fed
formula with b-16:0 is consistent with a neurochemical mechan-
ism, interfacing with the development of circadian rhythm and
limbic inhibition of spontaneous crying regulated via brainstem
mechanism. Melatonin and fatty acid ethanolamides, including
oleoyl ethanolamide, are possible targets for considerations as
mediators of the effects of formula fats. Of interest, Banni et al.
recently reported that feeding b-16:0 altered the endocannabi-
noid system and feed efﬁciency in post-weaning rats [53],
suggesting that structured triglycerides may have effects on
multiple physiological regulatory processes in young infants.7. Summary
Research on the physiological importance to young infants of
the unusual triglyceride structures in human milk, speciﬁcally the
preferential acylation of 16:0 at the sn-2 position, with large
amounts of 18:1n-9 at the sn-1,3 positions, is seeing regrowth of
interest, made possible in part by technological advances which
now make it possible to synthesize dietary triglycerides with the
structure 18:1n-9—16:0—18:1n-9. Early work linked the enrich-
ment of 16:0 at the sn-2 position of human milk triglycerides to a
high efﬁciency of fatty acid absorption, prevention of calciummalabsorption and softer stools in breast-fed infants. Recent studies
are now conﬁrming and extending these observations to show that
the sn-2 16:0 structure with 18:1n-9 on the triglyceride sn-1,3
positions also increases early bone mineralization and development,
inﬂuences the composition of the intestinal microﬂora, may lower
the extent and severity of intestinal inﬂammation in response to
insult, and may also have neurobiological effects that include
modulation of early infant crying. As discussed in this review of
recent studies, the effect of triglycerides enriched in sn-2 16:0, and
of b-16:0 itself is likely to extend well beyond fatty acid and mineral
absorption, although much remains to be learnt regarding biological
mechanism and potential implication for infant nutrition.Acknowledgments
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